0.86
+0(+0.00%)
Currency In USD
| Previous Close | 0.86 |
| Open | 0.86 |
| Day High | 0.9 |
| Day Low | 0.86 |
| 52-Week High | 7.98 |
| 52-Week Low | 0.86 |
| Volume | 11,406 |
| Average Volume | 365,040 |
| Market Cap | 1.56M |
| PE | -0.14 |
| EPS | -6.09 |
| Moving Average 50 Days | 1.15 |
| Moving Average 200 Days | 2.06 |
| Change | 0 |
If you invested $1000 in InMed Pharmaceuticals Inc. (INM) 10 years ago, it would be worth $0.5 as of February 21, 2026 at a share price of $0.86. Whereas If you bought $1000 worth of InMed Pharmaceuticals Inc. (INM) shares 5 years ago, it would be worth $0.36 as of February 21, 2026 at a share price of $0.86.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
InMed Announces Results of 2025 Annual General and Special Meeting
Newsfile
Dec 18, 2025 1:00 AM GMT
Vancouver, British Columbia--(Newsfile Corp. - December 17, 2025) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for disea
InMed Provides Update on BayMedica Commercial Business
Newsfile
Dec 12, 2025 10:31 PM GMT
Vancouver, British Columbia--(Newsfile Corp. - December 12, 2025) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for dise
InMed Announces Successful Completion of Pharmacokinetic Studies in Large Animal Model for Its Alzheimer's Disease Candidate INM-901
Newsfile
Nov 18, 2025 12:30 PM GMT
Data demonstrate a favorable bioavailability profile of INM-901 oral formulationData will support design and planning of first in human clinical trialsPreparing for pre-IND meeting with the FDA Vancouver, British Columbia--(Newsfile Corp. - November